Sign In
Buy VXRT
$0.519
-0.0111 (-2.09%)
At Close: Jun 23, 2026
5 Biotechs That Escaped the Coronavirus Onslaught Last Week
08:28am, Monday, 02'nd Mar 2020
Here we discuss 5 biotech stocks that outperformed the industry amid the U.S. market slump.
Market in Correction: 5 Stocks Resist Virus Attack in February
09:43am, Friday, 28'th Feb 2020
Wall Street has entered into the correction territory after steep coronavirus-induced selloffs in February. But these stocks have gained massively.
Vaxart Announces $10.0 Million Registered Direct Offering Priced At-the-Market
03:36pm, Thursday, 27'th Feb 2020
SOUTH SAN FRANCISCO, Calif., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than b
4 Healthcare Stocks to Gain as Coronavirus Threat Looms Large
09:08am, Wednesday, 26'th Feb 2020
Healthcare companies are trying to find a cure and contain the coronavirus outbreak. This keeps the industry in focus
Vaxart, Inc. (VXRT) Shares March Higher, Can It Continue?
09:10am, Tuesday, 25'th Feb 2020
As of late, it has definitely been a great time to be an investor in Vaxart, Inc. (VXRT).
Vaxart (VXRT) to Make Vaccines to Check Coronavirus, Stock Up
11:16am, Monday, 03'rd Feb 2020
Vaxart (VXRT) begins a program to develop a vaccine candidate to counter the new coronavirus infection. Shares jump.
Vaxart's stock rockets on heavy volume after initiating coronavirus vaccine development program
02:08pm, Friday, 31'st Jan 2020
Shares of Vaxart Inc. rocketed 54% on heavy volume in afternoon trading, putting them on track for the first close above the $1 mark in nearly 10 months, after the biotechnology company said it "initi
Vaxart Announces Initiation of Coronavirus Vaccine Program
08:00am, Friday, 31'st Jan 2020
Oral Vaccines based on Proprietary VAAST™ Platform Offer Potential Key Advantages in Global Quest to Develop Coronavirus Vaccine Oral Vaccines based on Proprietary VAAST™ Platform Offer Potential
The Wining Sector & Its Top Stocks in Virus-Infected January
07:20am, Friday, 31'st Jan 2020
January has turned out great for biotech stocks thanks to the coronavirus outbreak as well as a general upbeat trend.
Results from Influenza Challenge Study Published in Lancet Infectious Diseases
08:00am, Wednesday, 22'nd Jan 2020
Efficacy of Oral Tablet Vaccine Compares Favorably to Market-Leading Fluzone® Efficacy of Oral Tablet Vaccine Compares Favorably to Market-Leading Fluzone®
Vaxart, Inc. Announces Changes to its Board of Directors
08:00am, Monday, 28'th Oct 2019
The company has appointed four new members to the Board of Directors The company has appointed four new members to the Board of Directors
Vaxart Announces Pricing of $8 Million Underwritten Public Offering
10:20am, Thursday, 26'th Sep 2019
SOUTH SAN FRANCISCO, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biopharmaceutical company focused on the development of oral recombinant vaccines based
Endo Files BLA for CCH With the FDA for Cellulite Candidate (Revised)
04:56am, Tuesday, 10'th Sep 2019
Endo International (ENDP) files BLA for collagenase clostridium histolyticum (CCH) for the treatment of cellulite in the buttocks.
